Dialysis-related amyloidosis (DRA) is a complication that arises in patients who have been on long-term dialysis, particularly hemodialysis. It is characterized by the deposition of beta-2 microglobulin amyloid proteins in various tissues, leading to a range of symptoms and complications. The condition is most commonly observed in patients who have been undergoing dialysis for more than five years.
